New Details on the Revision of USP Chapter 1
Recommendation
14-16 October 2025
GMP Compliance and Technology for the Manufacture of Oral Solid Dosage Forms
Register now for ECA's GMP Newsletter
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
17.09.2025What Water Quality Is Required for Air Humidification in GMP Cleanrooms?
27.08.2025Insufficient Weight Uniformity in Tableting
27.08.2025Warning Letter to Indian API Manufacturer: Batch Release After Fire Incident
30.07.2025EDQM publishes three revised Texts on Pharmaceutical Water
30.07.2025US Manufacturer buys ‘Pharmaceutical Water’ in Grocery Store
30.07.2025VDI updates Cleanroom Guidelines 2083 Sheets 4.1 and 4.2